JFGIW
ENTA icon

Johnson Financial Group Inc (Wisconsin)’s Enanta Pharmaceuticals ENTA Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74K Hold
188
– – ﹤0.01% 749
2026
Q1 		$2.38K Hold
188
– – ﹤0.01% 768
2025
Q4 		$2.96K Hold
188
– – ﹤0.01% 765
2025
Q3 		$2.25K Buy
+188
New +$1.5K ﹤0.01% 922

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Johnson Financial Group Inc (Wisconsin)'s ENTA Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its Enanta Pharmaceuticals (ENTA) position steady in Q2 2026 at 188 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #749.

Johnson Financial Group Inc (Wisconsin) first reported a position in ENTA in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.96K in Q4 2025. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 188 shares of Enanta Pharmaceuticals worth $2.74K as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) left its Enanta Pharmaceuticals share count unchanged in Q2 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #749 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Enanta Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Enanta Pharmaceuticals position peaked at $2.96K in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.